AGILON
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Apr 2023)
What this means for you
This application is over — abandoned 10 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88626637
- Mark type
- Stylized text
- Filed
- 23 Sept 2019
- Published for opposition
- 14 Jan 2020
- Abandoned
- 10 Apr 2023
- Attorney of record
- Rimas Lukas
Goods and services
- Class 005 — Pharmaceuticals: Stem cells for therapeutic and medical purposes; allograft material, namely, human bone and tissue for surgical implants; biological bone tissue intended for subsequent implantation
Owner
- Biogennix, LLC, Irvine, CA, US
- Biogennix, LLC, Irvine, CA, US
Prosecution history
- 10 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Nov 2022 — SOU EXTENSION 5 GRANTED
- 12 Sept 2022 — SOU EXTENSION 5 FILED
- 24 Oct 2022 — NOTICE OF REVIVAL - E-MAILED
- 23 Oct 2022 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 23 Oct 2022 — PETITION TO REVIVE-GRANTED
- 23 Oct 2022 — TEAS PETITION TO REVIVE RECEIVED
- 17 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 17 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2022 — SOU EXTENSION 4 GRANTED
- 09 Mar 2022 — SOU EXTENSION 4 FILED
- 09 Mar 2022 — SOU TEAS EXTENSION RECEIVED